Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

caffeine, camylofin, ergotamine, mecloxamine, propyphenazone drug combination MeSH Supplementary Concept Data 2025


MeSH Supplementary
caffeine, camylofin, ergotamine, mecloxamine, propyphenazone drug combination
Unique ID
C002926
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C002926
Entry Term(s)
Avamigran
caffeine - camylofin - ergotamine - mecloxamine - propyphenazone
Registry Numbers
0
Previous Indexing
*AMINO ACIDS (73-75)
*AMINOPYRINE (1976-2010)
Heading Mapped to
*Caffeine
Drug Combinations
*Ergotamine
Glycine / analogs & derivatives
*Propylamines
*Pyrazolones
Frequency
3
Source
Lebanese Med J 25(4):316;1972
Date of Entry
1973/01/01
Revision Date
2014/10/22
caffeine, camylofin, ergotamine, mecloxamine, propyphenazone drug combination Preferred
Avamigran Narrower
page delivered in 0.004s